Life sciences companies often focus too narrowly on the decisions and actions around the time of prescribing. Investigating and understanding the whole care pathway can reveal new opportunities and provide a framework to engage all stakeholders across a healthcare system about the benefits and value of a medicine whilst at the same time aligning and coordinating the business towards shared objectives and goals; improving outcomes and creating value for patients, healthcare systems and the company.
Guidelines are supposed to ensure that the “right patients get the right treatments”, unfortunately they mostly just cover the diagnosis and treatment processes (see the diagram below). Ensuring the right patients get the right treatments requires that several different care processes operate in a coordinated and seamless manner. Care pathways describe all these sequences and steps that make up medical care.
Care pathways are crucial to informing health solution development, and when done effectively they provide an additional crucial insight: the barriers to changing clinical practice. There are many potential barriers which prevent or slow changes in clinical practice and behaviours. Often we see solutions developed with little real appreciation of what is preventing clinicians and HCPs delivering the great care they wish to.
PA’s Care Pathway approach enables companies to leverage their full business wide capabilities to realise the opportunities uncovered and capture the benefits for both themselves, their customers and patients. Our approach also provides a great platform for companies to engage key customers, stakeholders and opinion leaders differently and to bring them within the solution development process creating advocates to help drive solution implementation.